Should I Buy JAGX? JAGX 2026 Analysis

Should You Buy Jaguar Health Inc (JAGX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

0.680

1 Day change

-4.25%

52 Week Range

25.750

Analysis Updated At

2026/01/26

Jaguar Health Inc (JAGX) is not a good buy for a beginner investor with a long-term strategy at this time. The technical indicators are bearish, the financial performance is weak, and there are no significant positive catalysts or trading signals to suggest a strong entry point. Given the lack of clear growth prospects and the absence of favorable sentiment, holding off on this investment is recommended.

Technical Analysis

The MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 42.384, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level of 0.657, with resistance levels at 1.126 and above. Overall, the technical indicators suggest a bearish trend.

Options Data

Positive Catalysts

No significant positive catalysts specific to JAGX. Broader biotech sector activity, such as GSK's acquisition of Rapt Therapeutics, may create some speculative interest in the sector.

Neutral/Negative Catalysts

Weak financial performance in Q3 2025, including declining revenue (-0.80% YoY), net income (-3.57% YoY), and EPS (-76.11% YoY). Bearish technical indicators and lack of significant insider or hedge fund activity further weigh negatively on the stock.

Financial Performance

In Q3 2025, revenue dropped to $3,083,000 (-0.80% YoY), net income fell to -$9,502,000 (-3.57% YoY), and EPS dropped significantly to -6.28 (-76.11% YoY). Gross margin slightly improved to 82.74% (+0.18% YoY), but overall financial performance remains weak.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target changes available.

Analyst Rating

Wall Street analysts forecast JAGX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for JAGX is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold

Sell

Current: 0.705

Low

Averages

High